{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:08:17Z","timestamp":1782256097451,"version":"3.54.5"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T00:00:00Z","timestamp":1634860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.biopha.2021.112372","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T02:27:59Z","timestamp":1635388079000},"page":"112372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Anti-inflammatory and anti-fibrotic effects of modafinil in nonalcoholic liver disease"],"prefix":"10.1016","volume":"144","author":[{"given":"Shinkyu","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Aee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Eun","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huisu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minje","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk Hyo","family":"Suh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biopha.2021.112372_bib1","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/hep.28719","article-title":"Nonalcoholic fatty liver disease: epidemiology, natural history, and diagnostic challenges","volume":"64","author":"Cholankeril","year":"2016","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2021.112372_bib2","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.27678","article-title":"Challenges and opportunities in drug and biomarker development for nonalcoholic steatohepatitis: findings and recommendations from an American Association for the Study of Liver Diseases-U.S. Food and Drug Administration Joint Workshop","volume":"61","author":"Sanyal","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2021.112372_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0035-1562943","article-title":"Epidemiology and natural history of nonalcoholic fatty liver disease","volume":"35","author":"Satapathy","year":"2015","journal-title":"Semin Liver Dis."},{"issue":"6","key":"10.1016\/j.biopha.2021.112372_bib4","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2021.112372_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fimmu.2016.00123","article-title":"The cAMP pathway as therapeutic target in autoimmune and inflammatory diseases","volume":"7","author":"Raker","year":"2016","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112372_bib6","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1476-5381.2012.01847.x","article-title":"cAMP and Epac in the regulation of tissue fibrosis","volume":"166","author":"Insel","year":"2012","journal-title":"Br. J. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2021.112372_bib7","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1096\/fj.201700605R","article-title":"KCa2 channel localization and regulation in the axon initial segment","volume":"32","author":"Abiraman","year":"2018","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.biopha.2021.112372_bib8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.bbrc.2015.11.050","article-title":"Lyso-globotriaosylceramide downregulates KCa3.1 channel expression to inhibit collagen synthesis in fibroblasts","volume":"468","author":"Choi","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.biopha.2021.112372_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fphys.2017.00039","article-title":"Inhibition of intermediate-conductance calcium-activated K channel (KCa3.1) and fibroblast mitogenesis by alpha-linolenic acid and alterations of channel expression in the lysosomal storage disorders, fabry disease, and niemann pick C","volume":"8","author":"Olivan-Viguera","year":"2017","journal-title":"Front. Physiol."},{"issue":"24","key":"10.1016\/j.biopha.2021.112372_bib10","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1111\/febs.15329","article-title":"RUNX1 and TGF-beta signaling cross talk regulates Ca(2+) ion channels expression and activity during megakaryocyte development","volume":"287","author":"Raghuwanshi","year":"2020","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.biopha.2021.112372_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbrc.2017.05.009","article-title":"STIM1 and STIM2 differently regulate endogenous Ca(2+) entry and promote TGF-beta-induced EMT in breast cancer cells","volume":"488","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.biopha.2021.112372_bib12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bbrc.2016.01.152","article-title":"Role of protein kinase A and class II phosphatidylinositol 3-kinase C2beta in the downregulation of KCa3.1 channel synthesis and membrane surface expression by lyso-globotriaosylceramide","volume":"470","author":"Choi","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"18","key":"10.1016\/j.biopha.2021.112372_bib13","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1038\/onc.2013.187","article-title":"Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent","volume":"33","author":"Davis","year":"2014","journal-title":"Oncogene"},{"issue":"47","key":"10.1016\/j.biopha.2021.112372_bib14","doi-asserted-by":"crossref","first-page":"37137","DOI":"10.1074\/jbc.M003941200","article-title":"Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences","volume":"275","author":"Ghanshani","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2021.112372_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.phrs.2012.02.009","article-title":"Modafinil inhibits K(Ca)3.1 currents and muscle contraction via a cAMP-dependent mechanism","volume":"66","author":"Choi","year":"2012","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2021.112372_bib16","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.taap.2018.04.006","article-title":"The wakefulness promoting drug Modafinil causes adenosine receptor-mediated upregulation of receptor activator of nuclear factor kappaB ligand in osteoblasts: negative impact of the drug on peak bone accrual in rats","volume":"348","author":"Pal China","year":"2018","journal-title":"Toxicol. Appl. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2021.112372_bib17","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.tetasy.2004.01.039","article-title":"Synthesis and determination of the absolute configuration of the enantiomers of modafinil","volume":"15","author":"Prisinzano","year":"2004","journal-title":"Tetrahedron. Asymmetry"},{"issue":"2","key":"10.1016\/j.biopha.2021.112372_bib18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/iep.12008","article-title":"An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis","volume":"94","author":"Matsumoto","year":"2013","journal-title":"Int J. Exp. Pathol."},{"issue":"23","key":"10.1016\/j.biopha.2021.112372_bib19","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.3748\/wjg.v23.i23.4181","article-title":"Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease","volume":"23","author":"Paka","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112372_bib20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1165\/rcmb.2016-0092OC","article-title":"Inhibition of the KCa3.1 channel alleviates established pulmonary fibrosis in a large animal model","volume":"56","author":"Organ","year":"2017","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.biopha.2021.112372_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12931-014-0155-5","article-title":"Increased constitutive alphaSMA and Smad2\/3 expression in idiopathic pulmonary fibrosis myofibroblasts is KCa3.1-dependent","volume":"15","author":"Roach","year":"2014","journal-title":"Respir. Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.112372_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1476-5381.2009.00052.x","article-title":"Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?","volume":"156","author":"Feletou","year":"2009","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2021.112372_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.freeradbiomed.2019.12.025","article-title":"The impaired redox balance in peroxisomes of catalase knockout mice accelerates nonalcoholic fatty liver disease through endoplasmic reticulum stress","volume":"148","author":"Hwang","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"12","key":"10.1016\/j.biopha.2021.112372_bib24","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s00424-018-2195-z","article-title":"Catalase and nonalcoholic fatty liver disease","volume":"470","author":"Shin","year":"2018","journal-title":"Pflug. Arch."},{"issue":"11","key":"10.1016\/j.biopha.2021.112372_bib25","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/10715762.2013.837577","article-title":"Involvement of free radicals and oxidative stress in NAFLD\/NASH","volume":"47","author":"Sumida","year":"2013","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.biopha.2021.112372_bib26","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5820839","article-title":"Internalization and transportation of endothelial cell surface KCa2.3 and KCa3.1 in normal pregnancy and preeclampsia","volume":"2019","author":"Choi","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"issue":"4","key":"10.1016\/j.biopha.2021.112372_bib27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1089\/ars.2017.7038","article-title":"Altered redox state modulates endothelial KCa2.3 and KCa3.1 levels in normal pregnancy and preeclampsia","volume":"30","author":"Choi","year":"2019","journal-title":"Antioxid. Redox. Signal."},{"issue":"9","key":"10.1016\/j.biopha.2021.112372_bib28","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00424-017-1984-0","article-title":"Oxidative stress promotes myocardial fibrosis by upregulating KCa3.1 channel expression in AGT-REN double transgenic hypertensive mice","volume":"469","author":"Wang","year":"2017","journal-title":"Pflug. Arch."},{"issue":"5","key":"10.1016\/j.biopha.2021.112372_bib29","first-page":"354","article-title":"Level of serum and liver tissue TGF-beta1 in patients with liver fibrosis due to chronic hepatitis B","volume":"22","author":"Guo","year":"2008","journal-title":"Zhonghua Shi Yan He Lin. Chuang Bing. Du Xue Za Zhi"},{"issue":"2","key":"10.1016\/j.biopha.2021.112372_bib30","first-page":"112","article-title":"Serum transforming growth factor-beta1(TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected]","volume":"15","author":"Kirmaz","year":"2004","journal-title":"Eur. Cytokine Netw."},{"issue":"5","key":"10.1016\/j.biopha.2021.112372_bib31","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1053\/jhep.2002.32524","article-title":"Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis","volume":"35","author":"Corpechot","year":"2002","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2021.112372_bib32","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/hep.22849","article-title":"Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways","volume":"49","author":"Hassan","year":"2009","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.biopha.2021.112372_bib33","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4049\/jimmunol.173.2.776","article-title":"K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity","volume":"173","author":"Wulff","year":"2004","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2021.112372_bib34","first-page":"349","article-title":"Mechanisms of modafinil: a review of current research","volume":"3","author":"Gerrard","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"7","key":"10.1016\/j.biopha.2021.112372_bib35","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: a review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.biopha.2021.112372_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1021\/acschemneuro.7b00374","article-title":"An overview of the clinical uses, pharmacology, and safety of modafinil","volume":"9","author":"Murillo-Rodriguez","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biopha.2021.112372_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.105809","article-title":"Therapeutic treatment with Modafinil decreases the severity of experimental autoimmune encephalomyelitis in mice","volume":"75","author":"Brandao","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112372_bib38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2016.02.032","article-title":"Involvement of Ca(2+)-dependent hyperpolarization in sleep duration in mammals","volume":"90","author":"Tatsuki","year":"2016","journal-title":"Neuron"},{"issue":"13","key":"10.1016\/j.biopha.2021.112372_bib39","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2174\/092986707780831186","article-title":"Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications","volume":"14","author":"Wulff","year":"2007","journal-title":"Curr. Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.112372_bib40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0006-8993(96)00690-7","article-title":"Sleep cycle disturbances induced by apamin, a selective blocker of Ca(2+)-activated K+ channels","volume":"736","author":"Gandolfo","year":"1996","journal-title":"Brain Res."},{"issue":"4","key":"10.1016\/j.biopha.2021.112372_bib41","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/eji.200425954","article-title":"Blocking ion channel KCNN4 alleviates the symptoms of experimental autoimmune encephalomyelitis in mice","volume":"35","author":"Reich","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2021.112372_bib42","article-title":"A computational binding affinity estimation protocol with maximum utilization of experimental data: a case study for adenosine receptor","author":"Cho","year":"2020","journal-title":"ChemRxiv"},{"issue":"9","key":"10.1016\/j.biopha.2021.112372_bib43","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2165\/11315280-000000000-00000","article-title":"Armodafinil and modafinil have substantially different pharmacokinetic profiles despite having the same terminal half-lives: analysis of data from three randomized, single-dose, pharmacokinetic studies","volume":"29","author":"Darwish","year":"2009","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.biopha.2021.112372_bib44","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3389\/fimmu.2017.00859","article-title":"Differentially expressed potassium channels are associated with function of human effector memory CD8(+) T cells","volume":"8","author":"Sim","year":"2017","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112372_bib45","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/acel.12502","article-title":"KCa 3.1 upregulation preserves endothelium-dependent vasorelaxation during aging and oxidative stress","volume":"15","author":"Choi","year":"2016","journal-title":"Aging Cell"},{"issue":"8","key":"10.1016\/j.biopha.2021.112372_bib46","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.4103\/1673-5374.253529","article-title":"Hydrogen peroxide mediates pro-inflammatory cell-to-cell signaling: a new therapeutic target for inflammation?","volume":"14","author":"Gunawardena","year":"2019","journal-title":"Neural Regen. Res."},{"issue":"3","key":"10.1016\/j.biopha.2021.112372_bib47","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/jcb.24683","article-title":"Hydrogen peroxide as a damage signal in tissue injury and inflammation: murderer, mediator, or messenger?","volume":"115","author":"van der Vliet","year":"2014","journal-title":"J. Cell Biochem"},{"issue":"3","key":"10.1016\/j.biopha.2021.112372_bib48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4254\/wjh.v7.i3.377","article-title":"Angiogenesis and liver fibrosis","volume":"7","author":"Elpek","year":"2015","journal-title":"World J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112372_bib49","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbrc.2014.05.089","article-title":"Apamin inhibits hepatic fibrosis through suppression of transforming growth factor beta1-induced hepatocyte epithelial-mesenchymal transition","volume":"450","author":"Lee","year":"2014","journal-title":"Biochem Biophys. Res. Commun."},{"issue":"Pt 1","key":"10.1016\/j.biopha.2021.112372_bib50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1113\/jphysiol.2003.051896","article-title":"Small- and intermediate-conductance calcium-activated K+ channels provide different facets of endothelium-dependent hyperpolarization in rat mesenteric artery","volume":"553","author":"Crane","year":"2003","journal-title":"J. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112372_bib51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/path.4829","article-title":"Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances","volume":"241","author":"Lau","year":"2017","journal-title":"J. Pathol."},{"issue":"5","key":"10.1016\/j.biopha.2021.112372_bib52","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2021.112372_bib53","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cmet.2012.05.012","article-title":"Hyperresponsivity to low-dose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling","volume":"16","author":"Imajo","year":"2012","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.biopha.2021.112372_bib54","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2337\/diabetes.49.11.1939","article-title":"High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells","volume":"49","author":"Inoguchi","year":"2000","journal-title":"Diabetes"},{"issue":"25","key":"10.1016\/j.biopha.2021.112372_bib55","doi-asserted-by":"crossref","first-page":"22131","DOI":"10.1074\/jbc.M111883200","article-title":"Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression","volume":"277","author":"Hsu","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2021.112372_bib56","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0168-8278(03)00376-3","article-title":"Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis","volume":"39","author":"George","year":"2003","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2021.112372_bib57","doi-asserted-by":"crossref","first-page":"L295","DOI":"10.1152\/ajplung.00134.2010","article-title":"TGF-beta regulates Nox4, MnSOD and catalase expression, and IL-6 release in airway smooth muscle cells","volume":"300","author":"Michaeloudes","year":"2011","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2021.112372_bib58","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri3233","article-title":"Ion channels and transporters in lymphocyte function and immunity","volume":"12","author":"Feske","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2021.112372_bib59","doi-asserted-by":"crossref","first-page":"28770","DOI":"10.1038\/srep28770","article-title":"The calcium-activated potassium channel KCa3.1 is an important modulator of hepatic injury","volume":"6","author":"Sevelsted Moller","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2021.112372_bib60","first-page":"209","article-title":"Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease","volume":"30","author":"Papageorgiou","year":"2017","journal-title":"Ann. Gastroenterol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112372_bib61","first-page":"296","article-title":"Clinical implication of VEGF serum levels in cirrhotic patients with or without portal hypertension","volume":"5","author":"Assy","year":"1999","journal-title":"World J. Gastroenterol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221011562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221011562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:47:21Z","timestamp":1760100441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221011562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":61,"alternative-id":["S0753332221011562"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112372","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-inflammatory and anti-fibrotic effects of modafinil in nonalcoholic liver disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112372"}}